Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis.
We describe a case of reactivation of hepatitis D virus (HDV) in a patient treated with chemotherapy for a diffuse large B cell lymphoma despite lamivudine prophylaxis. This case suggests that previously cleared HDV should be considered when administering chemotherapy to patients with lymphoma.
Andersen
Ellen Sloth
ES
Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark. ellensloth@dadlnet.dk
Gerstoft
Jan
J
Weis
Nina
N
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003698:Hepatitis Delta Virus / Q000502:physiology*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications* / Q000188:drug therapy; D008297:Male; D011292:Premedication / Q000379:methods*; D018894:Reverse Transcriptase Inhibitors; D014775:Virus Activation / Q000187:drug effects*
D000970:Antineoplastic Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine